ABDI IBRAHIM ILAC SAN. VE TIC. A.S.
Abdi Ibrahim came into existence in 1912 with the goal of improving the health of the population with its strong vision, dynamic structure and modern outlook. As a leader in the pharmaceutical sector, Abdi Ibrahim employs the largest number of people, close to 3500 qualified personnel, and possesses the widest marketing and sales team within the sector. Abdi Ibrahim, possessing Turkey's first accredited R&D center, dedicates 6,5% of its annual turnover to research and development. The company has a portfolio of 180 brands, a production capacity of 565 million units and close to 30 licensors.
|Sales markets||Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America|
|Primary business activity||Manufacturer|
CPhI Worldwide 20189 - 11 October 2018 Madrid, Spain We were at stand 9G70 See our Exhibitor Profile See full Exhibitor List
CPHI Middle East & Africa 20183 - 5 September 2018 Abu Dhabi, UAE We were at stand D20 See our Exhibitor Profile See full Exhibitor List
Our Top products
Ferplex Oral Solution 40 mg
Ferplex oral solution 40 mg belongs to the antianemic drug category It is used for iron deficiency anemia Form: oral solution Active substances: fe iii (=80 mg protein succinylate) 40 mg/15 ml Package type: 15 ml x 10 flacon Licensor: italfarmaco spaMore info
Hametan cream belongs to the dermatologic products category It is used for wound healing agents Form: cream Active substances: standardized hamamelis virginiana extract 536 mg Package type: 30 g Al Tube Licensor: schwabeMore info
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation